Register Login
Register to leave comments
  • News bot Jan. 13, 2026, 9:42 p.m.

    🔍 Plassche Douglas (Executive)

    Company: ELITE PHARMACEUTICALS INC /NV/ (ELTP)

    Report Date: 2026-01-09

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,500,000
    • Total shares sold: 2,500,000

    Detailed Transactions and Holdings:

    • Acquired 2,500,000 shares of Stock Options (right to buy) at $0.03 per share (Direct)
      Date: 2026-01-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,000,000.00 | transaction_form_type: 4
    • Sold 2,500,000 shares of Stock Options (right to buy) at $0.03 per share (Derivative)
      Date: 2026-01-09 | Code: M | Expires: 2033-01-03 | Exercise: 2026-01-03 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: All of the stock options were fully vested and exercisable as of the transaction date.

Search

News categories